The Chicago Board Options Exchange (CBOE) has submitted a filing to list shares of a proposed staked Injective exchange-traded fund (ETF) by Canary Capital. This initiative reflects the growing acceptance of regulated crypto investment products in the United States. The ETF aims to earn staking rewards by providing validation services via an authorized staking platform. If approved, it would be the third staked altcoin ETF following recent approvals for other products. The CBOE filing arises in a favorable regulatory landscape under President Trump’s administration. The SEC has yet to formally acknowledge the ETF filings but typically responds within 30 to 45 days, with a complete review period that could extend up to 240 days. Should the ETF be accepted, it may enhance investor access to the Injective protocol’s governance token, potentially improving liquidity and visibility while helping the token recover from significant losses since its peak. Meanwhile, the cryptocurrency space has seen mixed reactions to recent ETF launches, highlighting the evolving dynamics of market sentiment toward these products.

Source 🔗